How to Buy Anthropic Stock

Can You Buy Anthropic Stock Today?

No shares of Anthropic trade on any public stock exchange today. Anthropic filed a Form S-1 registration statement with the Securities and Exchange Commission (SEC) on October 26, 2026, but the filing does not make shares immediately available for purchase. The initial public offering (IPO) process requires multiple regulatory steps before any member of the public can trade shares.

Investors can understand the path to public trading by tracking four distinct stages:

1. Current status: Anthropic Class A common stock has no public market. You cannot log into a brokerage account and buy shares today because no exchange lists the company.
2. Pricing stage: Anthropic and its underwriters must file an amended Form S-1 that fills in the estimated initial public offering price range and the planned number of shares.
3. Listing day: Once the registration statement becomes effective, the underwriters price the offering and the stock opens for public trading. At that point, investors can place a standard market order or limit order to buy ANT shares through any brokerage account.
4. Transactions to ignore: Investors should avoid private pre-IPO offers. These unregistered deals carry significant risk, including losing the entire investment.

Until listing day arrives, retail market orders cannot execute.

What the S-1 Says

The preliminary prospectus filed with the Securities and Exchange Commission (SEC) provides initial disclosures about the corporate structure, underwriters, and reported financial results. Anthropic is incorporated as a public benefit corporation under Delaware law. The filing states that prior to this offering, there has been no public market for the company's Class A common stock. All reported figures represent the company's own accounting disclosures rather than an independent market valuation.

In our review of the filed Form S-1, we searched the full text for a directed share program, a reserved-share program, and any retail allocation, and found none for U.S. retail investors; the filing mentions only a separate European retail offering under its own prospectus, and says that the representatives may agree to allocate a number of shares of Class A common stock to underwriters for sale to their online brokerage account holders.

The financial disclosures show that the company generated $16,286 million in revenue during the first six months of 2026, compared to $1,163 million during the first six months of 2025. Operating loss narrowed from $2,135 million to $693 million across those same periods. Net loss widened to $80,748 million for the six months ended June 30, 2026, driven by a $72,388 million change in fair value of convertible notes, derivative liabilities, and simple agreements for future equity (SAFEs). The Form S-1 explicitly notes that the results for the six-month period are not indicative of results for the full financial year.

How Retail Investors Get IPO Shares

Retail access to initial public offering shares before exchange trading begins is limited for most retail investors and underwriting distribution rules. The SEC investor bulletin on IPOs explains that underwriters distribute the majority of initial public offering shares to institutional accounts and high-net-worth clients first. Because of this distribution model, most individual investors can only purchase shares once the stock begins trading on the secondary market, which frequently opens at a price above the original initial public offering price.

Underwriting distributions are regulated under FINRA Rule 5131, which governs new issue allocations and distributions. Anthropic's Form S-1 registration statement notes that the lead representatives may allocate shares to underwriters for distribution to their online brokerage account holders. The filing also states that the underwriters do not expect sales to discretionary accounts to exceed five percent of the total shares offered. To learn more about how public offerings function, review our guide on what is an IPO.

If you want to participate in an offering before public trading starts, you must ask your individual brokerage firm whether it offers initial public offering access and what eligibility criteria it enforces. The filing guarantees no shares to U.S. retail account holders.

Pre-IPO Offers and Scams

Unsolicited opportunities to purchase private shares before an initial public offering carry real risk. According to the Investor.gov pre-IPO alert issued on June 7, 2024, pre-IPO investing carries substantial risk, including the potential loss of your entire investment principal. Private pre-IPO offerings are not registered with the Securities and Exchange Commission (SEC), and offerings marketed broadly to the general public may be illegal.

The Investor.gov alert names these risks of pre-IPO investing:

• No public listing: The company may delay its plans indefinitely or cancel its public offering altogether.
• No resale market: A secondary trading market may never develop, leaving buyers unable to resell or transfer their holdings.

The alert highlights multiple warning signs associated with private stock solicitations. Red flags include unregistered individuals or firms offering private equity deals, aggressive sales tactics such as unsolicited cold calls, marketing pushes on social media channels, and high-pressure claims centered around popular emerging technologies. Before transferring money to any entity promising access to private shares, verify the registration status of the seller using the free registration check on Investor.gov.

Lock-Up and What Happens After Listing

The Form S-1 registration statement establishes a 180-day lock-up and market standoff period for company insiders and certain stockholders, along with an extended 365-day lock-up period for specified holders. The filing notes that the underwriting representatives retain discretionary authority to release lock-up securities in whole or in part prior to expiration.

The SEC lock-up guide notes that lock-up agreements restrict company insiders from selling their shares for a designated window of time following a public listing. Once these contractual restrictions expire or underwriters grant releases, substantial blocks of previously restricted shares can enter public circulation and reach the market.

What to Do While You Wait

Investors preparing for a future public listing can take practical steps to educate themselves and manage financial risk. First-time equity buyers can review core fundamentals in our guide on how to start investing.

• Read the primary regulatory filing: Review the complete text and operational risk factors in the Anthropic Form S-1 on the SEC EDGAR system.
• Monitor future amendments: Watch the SEC filing feed for an amended Form S-1 that populates the anticipated share price range and the exact number of Class A shares offered.
• Restrict single-stock risk: Maintain disciplined asset allocation limits to avoid overexposing your savings to a single company, as detailed in our guide on concentrated stock position risk.
• Examine historical precedents: Read our overview of how to buy SpaceX stock, which covers the purchase steps now that SpaceX trades on Nasdaq as SPCX, since June 12, 2026.

Our Takeaway

You cannot buy Anthropic stock today because no shares trade on any public stock exchange. The realistic avenues for acquiring shares later are an initial public offering allocation through a broker that offers IPO access or placing an order for ANT on Nasdaq after public trading commences. The Form S-1 filing notes that underwriters may allocate shares to their online brokerage account holders, but it promises U.S. retail investors nothing.

Investors should reject private pre-IPO solicitations, which the Securities and Exchange Commission (SEC) warns carry the risk of losing the entire investment and of scams. Wait for the updated Form S-1 filing to disclose the proposed share count and price range before making portfolio decisions, and keep single-stock allocations sized defensively. This assessment is based on our review of the Form S-1 and official regulatory releases, not a product test. Our takeaway will update if an amended registration statement introduces a formal retail allocation or alters the proposed listing structure.

Frequently asked questions